Amalgamated Bank’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,437
Closed -$1K 3172
2024
Q1
$1K Sell
1,437
-4,597
-76% -$3.33K ﹤0.01% 2953
2023
Q4
$5K Sell
6,034
-428
-7% -$413 ﹤0.01% 2953
2023
Q3
$9K Hold
6,462
﹤0.01% 2923
2023
Q2
$16K Buy
+6,462
New +$13.7K ﹤0.01% 2858

Other funds holding VAXX

Amalgamated Bank's VAXX Position: Q2 2024 in Review

Amalgamated Bank sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 1,437 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in VAXX in Q2 2023 and held it in 4 quarters. The position peaked at $16K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Amalgamated Bank reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 1,437 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $1K.
  • Amalgamated Bank first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2023 and held it in 4 quarters.
  • Amalgamated Bank's Vaxxinity, Inc. Class A Common Stock position peaked at $16K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.